Iveric Bio Stock Retained Earnings
ISEEDelisted Stock | USD 39.95 0.00 0.00% |
IVERIC Bio fundamentals help investors to digest information that contributes to IVERIC Bio's financial success or failures. It also enables traders to predict the movement of IVERIC Stock. The fundamental analysis module provides a way to measure IVERIC Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IVERIC Bio stock.
IVERIC |
IVERIC Bio Company Retained Earnings Analysis
IVERIC Bio's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current IVERIC Bio Retained Earnings | (864.81 M) |
Most of IVERIC Bio's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IVERIC Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
CompetitionBased on the latest financial disclosure, IVERIC Bio has a Retained Earnings of (864.81 Million). This is 192.85% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The retained earnings for all United States stocks is 109.27% higher than that of the company.
IVERIC Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IVERIC Bio's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IVERIC Bio could also be used in its relative valuation, which is a method of valuing IVERIC Bio by comparing valuation metrics of similar companies.IVERIC Bio is currently under evaluation in retained earnings category among its peers.
IVERIC Fundamentals
Return On Equity | -0.55 | |||
Return On Asset | -0.3 | |||
Current Valuation | 4.98 B | |||
Shares Outstanding | 137.98 M | |||
Shares Owned By Insiders | 0.65 % | |||
Shares Owned By Institutions | 99.35 % | |||
Number Of Shares Shorted | 16.64 M | |||
Price To Earning | 4.17 X | |||
Price To Book | 3.81 X | |||
Gross Profit | (117.01 M) | |||
EBITDA | (192.28 M) | |||
Net Income | (185.21 M) | |||
Cash And Equivalents | 311.96 M | |||
Cash Per Share | 2.64 X | |||
Total Debt | 97.77 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 11.98 X | |||
Book Value Per Share | 3.48 X | |||
Cash Flow From Operations | (163.77 M) | |||
Short Ratio | 5.25 X | |||
Earnings Per Share | (1.82) X | |||
Target Price | 39.1 | |||
Number Of Employees | 163 | |||
Beta | 1.1 | |||
Market Capitalization | 5.51 B | |||
Total Asset | 666.82 M | |||
Retained Earnings | (864.81 M) | |||
Working Capital | 627.24 M | |||
Current Asset | 121.07 M | |||
Current Liabilities | 14.54 M | |||
Z Score | 32.19 | |||
Net Asset | 666.82 M |
About IVERIC Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IVERIC Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IVERIC Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IVERIC Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in IVERIC Stock
If you are still planning to invest in IVERIC Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IVERIC Bio's history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |